PLPP2: A Unique Protein with Potential as A Drug Or Biomarker

Target Name: PLPP2

NCBI ID: G8612

PLPP2

PLPP2: A Unique Protein with Potential as A Drug Or Biomarker

PLPP2 (poly (L-leucine) peptide-2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is made up of a unique sequence of amino acids that is derived from leucine, which is a protein that is found in all proteins.

One of the things that makes PLPP2 unique is its structure. PLPP2 is made up of a long, linear molecule that is composed of multiple copies of the amino acid leucine. The sequence of leucine molecules in PLPP2 is specifically designed to interact with certain proteins, known as nuclear factor kappa B (NFkB) proteins. These proteins are involved in a variety of cellular processes, including inflammation, metabolism, and stress response.

PLPP2 has been shown to play a role in several different diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that PLPP2 is often overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that PLPP2 may be a promising target for cancer therapies.

In addition to its potential as a drug or biomarker, PLPP2 is also of interest to researchers because of its unique structure and function. The researchers are still working to fully understand the precise role of PLPP2 in various biological processes, but they are confident that it will continue to be an important focus of research in the years to come.

Overall, PLPP2 is a protein that is still being studied and understood, but it is clear that it has the potential to be a valuable drug or biomarker in the future.

Protein Name: Phospholipid Phosphatase 2

Functions: Magnesium-independent phospholipid phosphatase that catalyzes the dephosphorylation of a variety of glycerolipid and sphingolipid phosphate esters including phosphatidate/PA, lysophosphatidate/LPA, sphingosine 1-phosphate/S1P and ceramide 1-phosphate/C1P (PubMed:9705349, PubMed:9607309, PubMed:16467304). Has no apparent extracellular phosphatase activity and therefore most probably acts intracellularly (PubMed:16467304). Also acts on N-oleoyl ethanolamine phosphate/N-(9Z-octadecenoyl)-ethanolamine phosphate, a potential physiological compound (PubMed:9607309). Through dephosphorylation of these bioactive lipid mediators produces new bioactive compounds and may regulate signal transduction in different cellular processes (Probable). Indirectly regulates, for instance, cell cycle G1/S phase transition through its phospholipid phosphatase activity (By similarity)

The "PLPP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLPP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets